Sahar Greish

Dr. Sahar Greish

Faculty of medicine - Suez Canal University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MHMona Hussain
Mona Hussain
NANoha Abogresha
Noha Abogresha
GAGhada AbdelKader
Ghada AbdelKader
RHRanya Moustafa Hassan
Ranya Moustafa Hassan
EAEman Z. Abdelaziz
Eman Z. Abdelaziz
SGSahar Greish
Sahar Greish
Doxorubicin is a drug that belongs to the anthracycline antibiotics. Nephrotoxicity is one of the serious side effects of doxorubicin treatment. Crocin, which is one of the most bioactive components of saffron, has antioxidant, anti‐inflammatory, and antitumor effects. The current study was aimed at investigating the possible protective effects of crocin against doxorubicin‐induced nephrotoxicity to elucidate the underlying mechanism of this effect. The study included four groups, six rats in each group: normal control, crocin control, doxorubicin, and crocin/doxorubicin. Doxorubicin and crocin/doxorubicin groups received intraperitoneal injections of doxorubicin (3.5 mg/kg twice weekly for 3 weeks). Rats in the crocin control group and the crocin/doxorubicin group were treated with intraperitoneal injections of crocin (100 mg/kg body weight per day) for 3 weeks. Biomarkers of kidney function and oxidative stress as well as the abundance of mRNA for nuclear factor‐κβ and inducible nitric oxide synthase were evaluated. In addition, the abundance of cyclooxygenase 2 and tumor necrosis factor α immunoreactivity was evaluated. Crocin treatment had renoprotective effects manifested by significant improvement in kidney function as well as a reduction in the abundance of biomarkers of oxidative stress markers and inflammatory mediators. In conclusion, crocin has a protective effect against doxorubicin‐induced nephrotoxicity in rats by serving as an antioxidant and attenuating the expression of NF‐κB, iNOS, COX2, and TNFα.

1 January 2012 in World Journal of Stem Cells
Verified
Journal Article
Open access
SGSahar Greish
Sahar Greish
NANoha Abogresha
Noha Abogresha
ZAZeinab Abdel-Hady
Zeinab Abdel-Hady
EZEman Zakaria
Eman Zakaria
MGMona Ghaly
Mona Ghaly
MHMohamed Hefny
Mohamed Hefny
Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model

Verified
Journal Article
Open access
PDF file
NANoha Abogresha
Noha Abogresha
SMSally Mohammed
Sally Mohammed
MHMarwa Hosny
Marwa Hosny
HIHoda Ibrahim
Hoda Ibrahim
AGAhmed M. Gadallah
Ahmed M. Gadallah
SGSahar Greish
Sahar Greish
The current study was designed to investigate the protective role of diosmin against cyclophosphamide-induced premature ovarian insufficiency (POI). Female Swiss albino rats received a single intraperitoneal dose of cyclophosphamide (200 mg/kg) followed by 8 mg/kg/day for the next 15 consecutive days either alone or in combination with oral diosmin at 50 or 100 mg/kg. Histopathological examination of ovarian tissues, hormonal assays for follicle stimulating hormone (FSH), estradiol (E2), and anti-Mullerian hormone (AMH), assessment of the oxidative stress status, as well as measurement of the relative expression of miRNA-145 and its target genes [vascular endothelial growth factor B (VEGF-B) and regulator of cell cycle (RGC32)] were performed. Diosmin treatment ameliorated the levels of E2, AMH, and oxidative stress markers. Additionally, both low and high diosmin doses significantly reduced the histopathological alterations and nearly preserved the normal ovarian reserve. MiRNA-145 expression was upregulated after treatment with diosmin high dose. miRNA-145 target genes were over-expressed after both low and high diosmin administration. Based on our findings, diosmin has a dose-dependent protective effect against cyclophosphamide-induced ovarian toxicity in rats.

10 January 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
HAHeba Abdelrazek
Heba Abdelrazek
MMManal M. A. Mahmoud
Manal M. A. Mahmoud
HTHend M. Tag
Hend M. Tag
SGSahar Greish
Sahar Greish
DEDalia A. Eltamany
Dalia A. Eltamany
MSMohammed T. A. Soliman
Mohammed T. A. Soliman
Hormone replacement therapy (HRT) can alleviate estrogen deficiency symptoms especially during menopause. The present study aimed at investigating the effect of soy isoflavones as HRT on immunological and bone health-related parameters with a special focus on the interactions between immunological status and metabolism. Thirty healthy cyclic female Wistar rats were used in this experiment. Ten females were sham-operated, and 20 females were subjected to ovariectomy. Overiectomized (OVX) female rats were randomly divided into 2 groups: the control group (G1, OVX/casein) was fed a casein-based diet, and the second group (G2, OVX/soy) was fed a high soy isoflavone diet. Both groups were compared to a sham-operated group (G3, sham/casein). Treatments continued for 7 weeks. Feed intake, weight gain, and lymphoid organ relative weights were recorded. Some metabolic, immunological, and bone health-related parameters were measured. Moreover, nitric oxide (NO), malondialdehyde (MDA), and total antioxidant capacity (TAC) were determined. Bone histopathology and immunohistochemistry to estrogen receptor alpha (ERα) were done. Feeding soy to OVX females reduced feed intake, weight gain, relative lymphoid organ weight, and T-lymphocytes transformation. Soy isoflavone administration normalized nearly all metabolic and immunological parameters to a level comparable to the sham group via oxidative stress amelioration and bone ERα promotion. Soy isoflavones seemed to be good HRT in estrogen deprivation which modulated the appetite, weight gain, lipid profile, proinflammation, and bone turnover.

1 January 2016 in Archives of Medical Science
Verified
Journal Article
Open access
NANoha Abogresha
Noha Abogresha
SGSahar Greish
Sahar Greish
EAEman Z. Abdelaziz
Eman Z. Abdelaziz
WKWaleed F. Khalil
Waleed F. Khalil
Introduction: Recent studies have demonstrated remote effects of renal ischemia/reperfusion (IR) injury on some organs such as brain, liver, and lungs. Oxidative stress is reported to be the cornerstone in such ischemic conditions. Associated apoptosis is also reported in remote lung, liver...

1 December 2011 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MEMohamed A. Elsharawy
Mohamed A. Elsharawy
MNMagda Naim
Magda Naim
SGSahar Greish
Sahar Greish
Diabetic patients with foot ulcers usually manifest with high amputation and mortality rates. Preliminary evidence supports the effectiveness of stem cell (St) therapy on diabetic foot ulcers. The objective of this study was to evaluate the efficacy of stem cells in the healing of wounds among streptozotocin-induced diabetic albino rats. Thirty male albino rats were divided into three groups each of 10 rats: control group, diabetic control (DC) group and St group. Diabetes was induced by intra-peritoneal injection of streptozotocin. A full thickness circular wound of ∼10 mm in diameter was performed on the front of right legs of all rats. In the diabetic St group, the wounds were treated by injection of umbilical cord blood-derived CD34+ stem cells into the wound bed. Half of each group rats were sacrificed after 1 week and the rest after 2 weeks. The wound areas were used for histopathology, immunohistochemistry and transmission electron microscope studies. Assessment of wound surface area, epidermal thickness, blood vessel proliferation and collagen deposition were performed. There was a significant decrease in mean wound surface area, increase in mean epidermal thickness, blood vessel proliferation and collagen deposition in the St group compared with the DC group. Treatment with CD34+-enriched cells decreased wound size, accelerated epidermal healing and dramatically accelerated revascularization of the wounds compared with the DC group.